Jan 26,2016

Bionic pancreas dev Bigfoot Biomedical reels in $2.4m

Bionic pancreas developer Bigfoot Biomedical raised $2.4 million in a new round of debt financing, according to an SEC filing posted yesterday.

FUNDING SEED ROUND
View Analyst & Ambassador Comments
Go to original news
Feb 17,2016

POPS! Diabetes Care Raises $500K to Improve Diabetes Management

POPS! Diabetes Care – a 2015 MN Cup Finalist – has completed a half-million dollar capital raise led by TreeHouse Health, an innovation center designed to invest in emerging healthcare companies and help accelerate their growth. POPS! is developing a mobile solution for patients with diabetes to better self-manage, and for healthcare providers to efficiently expand their reach to patients.

FUNDING DEBT FINANCING
View Analyst & Ambassador Comments
Go to original news
Mar 01,2016

Johnson & Johnson joins WellDoc’s big funding round

WellDoc’s Series B just got closer to $30 million. The Midtown-based company, which makes an app for managing type 2 diabetes, announced a total of $29.5 million in its Series B on Tuesday. In December, company officials said they raised $22 million, led by Samsung Ventures and Merck Global Health Innovation Fund.

FUNDING SERIES B
View Analyst & Ambassador Comments
Go to original news
Apr 01,2016

Introducing Beta Bionics: Bringing the iLet Bionic Pancreas to Market

Breaking news today from Boston, where Dr. Ed Damiano of the Bionic Pancreas team disclosed the launch of “Beta Bionics” – a new “public benefit corporation” to commercialize the team’s fully integrated iLet Bionic Pancreas device to automate delivery of insulin and glucagon. Lilly has also invested $5 million in Beta Bionics, a major vote of confidence in the team. The company’s website went live today at betabionics.com.

FUNDING SERIES A
View Analyst & Ambassador Comments
Go to original news
May 02,2016

Dexcom Raises $7.2 M in Equity Round

Dexcom Inc. secured $7.2 million from the investors according to the SEC form registered.

FUNDING POST-IPO EQUITY
View Analyst & Ambassador Comments
Go to original news
Jun 01,2016

Fruit Street Health raises additional $1.4M in crowdfunding push for telehealth

Fruit Street Health, a telehealth startup with a joint venture with VSee, has raised $5.4 million in the past year from 120 physicians a crowdfunding push, according to an amended Form D filing with the U.S. Securities and Trade Commission. In November, Fruit Street announced it had raised $4 million from 60 physicians. The amended filing shows it has raised an additional $1.4 million since then from 50 more doctors.

FUNDING SERIES A
View Analyst & Ambassador Comments
Go to original news
Jun 22,2016

Terumo snags $17.4M in fed funding to study its Mirasol-treated platelets in plasma

Japanese devicemaker Terumo has been awarded $17.4 million in initial funding from the U.S. government to study its Mirasol pathogen reduction system for the treatment of patients with hypoproliferative thrombocytopenia.

FUNDING GRANT
View Analyst & Ambassador Comments
Go to original news
Jun 23,2016

FareWell raises $8.5M for digital coaching weight loss service

San Francisco-based FareWell has raised $8.5 million for an online program aimed at preventing chronic diseases by addressing obesity as a root cause. The funding comes from individual investors including David Perry, the company's cofounder and chairman.

FUNDING FUNDING ROUND
View Analyst & Ambassador Comments
Go to original news
Jul 12,2016

Teladoc Secures $50 Million in Debt Financing from Silicon Valley Bank

Teladoc, Inc. (NYSE:TDOC), the first and largest telehealth platform in the United States, today announced that it has entered into a $25 million term loan and $25 million revolving line of credit agreement with Silicon Valley Bank (SVB), the bank of the world’s most innovative companies and their investors. This agreement provides up to $50 million of new capital to the company to be used for general corporate purposes.

FUNDING POST-IPO DEBT
View Analyst & Ambassador Comments
Go to original news
Jul 12,2016

Teladoc Raises $80M in Equity Financing

Teladoc, Inc. registered a SEC form stating $80 million funding from the investors in an equity round.

FUNDING POST-IPO EQUITY
View Analyst & Ambassador Comments
Go to original news
Subscribe to DIABETES